Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease
published in: Journal of Clinical Oncology
date of publication: 2016-01-25
language: English
main subject: stem cell transplantation
Cites articles 40
- 2011-06
- 2011-07-06
Date
Title
Article - wd:Q35904666